Showing results (31-40 of 46) with videos related to

Sort By:
Pageof 5
The Journal of Nervous and Mental Disease|December 3, 2011
The influence of posttraumatic stress disorder numbing and hyperarousal symptom clusters in the prediction of physical health status in veterans with chronic tobacco dependence and posttraumatic stress disorderLaura H Harder, Shuo Chen, Dewleen G Baker, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|October 14, 2004
Effects of omalizumab, a humanized monoclonal anti-IgE antibody, on nasal reactivity to allergen and local IgE synthesisJonathan Corren, David Diaz-Sanchez, Andrew Saxon, et al.
Annual Review of Medicine|September 22, 2006
New reagents on the horizon for immune toleranceE William St Clair, Larry A Turka, Andrew Saxon, et al.
Journal of Psychosomatic Research|August 2, 2012
PTSD and depression as predictors of physical health-related quality of life in tobacco-dependent veteransLaura H Aversa, Jill A Stoddard, Neal M Doran, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 23, 2019
Inhibition of Allergic Reactivity through Targeting FcεRI-Bound IgE with Humanized Low-Affinity AntibodiesKe Zhang, Michael Elias, Hong Zhang, et al.
Contemporary Clinical Trials|November 20, 2012
Cocaine use reduction with buprenorphine (CURB): rationale, design, and methodologyLarissa J Mooney, Suzanne Nielsen, Andrew Saxon, et al.
Addiction Science & Clinical Practice|January 18, 2020
Developing a clinical decision support for opioid use disorders: a NIDA center for the clinical trials network working group reportGavin B Bart, Andrew Saxon, David A Fiellin, et al.
JAMA Network Open|July 15, 2021
High-Dose Buprenorphine Induction in the Emergency Department for Treatment of Opioid Use DisorderAndrew A Herring, Aidan A Vosooghi, Joshua Luftig, et al.
Addiction (Abingdon, England)|January 20, 2009
Buprenorphine tapering schedule and illicit opioid useWalter Ling, Maureen Hillhouse, Catherine Domier, et al.
The Journal of Biological Chemistry|May 21, 2004
Co-aggregation of FcgammaRII with FcepsilonRI on human mast cells inhibits antigen-induced secretion and involves SHIP-Grb2-Dok complexesChristopher L Kepley, Sharven Taghavi, Graham Mackay, et al.
Pageof 5